Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28620
Abstract: Chronic hepatitis B (CHB) still cannot be cured currently, while the pursuit of a functional cure seems to be an accessible goal, in which the condition mainly depends on the serum hepatitis B surface antigen… read more here.
Keywords: hbsag; trcp; ubiquitin ligase; hbsag levels ... See more keywords
HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14030584
Abstract: A comprehensive characterization of chronic HBV (CHB) patients is required to guide therapeutic decisions. The cumulative impact of classical and novel biomarkers on the clinical categorization of these patients has not been rigorously assessed. We… read more here.
Keywords: hbv rna; hbsag; hbv; hbsag levels ... See more keywords
Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v24.i6.725
Abstract: AIM To investigate the utility of hepatitis B surface antigen (HBsAg) kinetics in chronic hepatitis B patients during long-term entecavir treatment. METHODS This retrospective study included treatment-naïve chronic hepatitis B patients who received at least… read more here.
Keywords: hepatitis; treatment; hbsag levels; antigen ... See more keywords